Visudyne and Retinal tear - a phase IV clinical study of FDA data

Summary:

Retinal tear is reported as a side effect among people who take Visudyne (verteporfin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Eylea, and have Macular degeneration.

The phase IV clinical study analyzes which people have Retinal tear when taking Visudyne. It is created by eHealthMe based on reports of 3,123 people who have side effects when taking Visudyne from the FDA, and is updated regularly.

What is Visudyne?

Visudyne has active ingredients of verteporfin. eHealthMe is studying from 3,124 Visudyne users. Check the latest studies of Visudyne.

What is Retinal tear?

Retinal tear is found to be associated with 326 drugs and 468 conditions by eHealthMe. Check the latest studies of Retinal tear.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,123 people reported to have side effects when taking Visudyne.
Among them, 31 people (0.99%) have Retinal tear.

Among these 31 people:

How long have people been on Visudyne when they have Retinal tear? *

What is the gender of people who have Retinal tear when taking Visudyne? *

female: 29.03 %
male: 70.97 %

What is the age of people who have Retinal tear when taking Visudyne? *

What are other drugs people take besides Visudyne? *

What are other side effects people have besides Retinal tear? *

Visual Acuity Reduced (reduced clearness of vision): 12 people, 38.71%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 11 people, 35.48%
Detachment Of Retinal Pigment Epithelium: 7 people, 22.58%
Disease Progression: 6 people, 19.35%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 5 people, 16.13%
Eye Haemorrhage (bleeding in the eye): 5 people, 16.13%
Retinal Haemorrhage (bleeding from retina): 4 people, 12.90%
Visual Disturbance: 4 people, 12.90%
Retinal Pigment Epithelial Tear (pigment epithelial tear of retina): 3 people, 9.68%
Chest Pain: 2 people, 6.45%

What are the existing conditions these people have? *

Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 19 people, 61.29%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 9.68%
Age-Related Macular Degeneration: 3 people, 9.68%
Retinal Aneurysm (an abnormal dilatation of an retinal artery): 2 people, 6.45%
Polypoidal Choroidal Vasculopathy (polyp-like sub-retinal pigment epithelium vascular abnormalities predominantly found in the macula and peripapillary region): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Visudyne and have Retinal tear?

- Check whether Retinal tear is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Visudyne:

Visudyne (3,124 reports)

Retinal tear treatments and more:

Retinal tear (2,985 reports)

Browse all side effects of Visudyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal tear:

Retinal tear (326 drugs)

Browse all the conditions that are associated with Retinal tear:

Retinal tear (468 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on verteporfin (the active ingredients of Visudyne) and Visudyne (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.